LSDIF.US Lucy Scientific Discovery Inc.
- Market cap
- USD 176.00
- P/E
- -
- P/B
- 0.00x
- ROE
- -11,379.2%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Dec 2023.
Is LSDIF.US undervalued?
Graham numberThe Graham number of Lucy Scientific Discovery Inc. cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Lucy Scientific Discovery Inc. fundamental analysis
No fundamental analysis for Lucy Scientific Discovery Inc. yet.
Lucy Scientific Discovery Inc. stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Lucy Scientific Discovery Inc.
Lucy Scientific Discovery Inc., an early stage psychotropics contract manufacturing company, engaged in the research, manufacturing, and commercialization of psychedelic products. The company offers biological raw materials, active pharmaceutical ingredients, and finished biopharmaceutical products. It also develops and produces highly controlled agricultural grow environments for plant manufacturing and replication applications. The company was formerly known as Hollyweed N…
Full company profileLucy Scientific Discovery Inc. financial statements
2023 annualized: Fiscal year 2023 is not finished. Income statement and cash flow are annualized from 2 quarters up to Dec 31, 2023, the balance sheet is the latest quarter. Figures change when the annual report is published.
Lucy Scientific Discovery Inc. annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2021 | 2022 | 2023 | 2023 Anlz |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | 0.00 | 0.00 | 7.05K | 19.4K |
| Gross Profit | - | 0.00 | 2.55K | - |
| Operating Income | -2.51M | -3.47M | -5.77M | -4.75M |
| EBITDA | - | -3.79M | -6.92M | - |
| Net Income | -4.73M | -5.86M | -8.99M | -9.24M |
| EPS | -3.10 | -3.85 | -5.15 | -5.23 |
| Balance Sheet | ||||
| Total Assets | 5.55M | 4.63M | 8.78M | 4.29M |
| Total Liabilities | 11.9M | 9.41M | 4.10M | 4.21M |
| Shareholders' Equity | -6.36M | -4.78M | 4.68M | 81.2K |
| Cash & Short-term Investments | 246K | 53.4K | 1.67M | 211K |
| Cash Flow | ||||
| Operating Cash Flow | -1.48M | -2.42M | -4.27M | -4.06M |
| Capital Expenditure | 0.00 | 34.1K | 300K | 246K |
| Free Cash Flow | -1.48M | -2.45M | -4.57M | -4.30M |
| Ratios | ||||
| ROE | - | - | -192.1% | -11,379.2% |
| ROA | -85.1% | -126.4% | -102.4% | -215.4% |
| Net Profit Margin | - | - | -127,532.0% | -47,682.5% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Lucy Scientific Discovery Inc. dividends
Lucy Scientific Discovery Inc. has not paid dividends in the last 3 fiscal years.
Last stock split: 1:10 on Feb 26, 2024.
Who owns Lucy Scientific Discovery Inc.
Ownership data of Lucy Scientific Discovery Inc. is not available yet.
Lucy Scientific Discovery Inc. company profile
- Company name
- Lucy Scientific Discovery Inc.
- Ticker
- LSDIF.US
- ISIN
- CA54960E2033
- Exchange
- USA Stocks
- Listed since
- Feb 9, 2023
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Employees
- 2
- Fiscal year end
- June
- Address
- 1321 Blanshard Street, Victoria, BC, Canada, V8W 0B6
- Phone
- 778 410 5195
- Website
- lucyscientific.com
About Lucy Scientific Discovery Inc.
Lucy Scientific Discovery Inc., an early stage psychotropics contract manufacturing company, engaged in the research, manufacturing, and commercialization of psychedelic products. The company offers biological raw materials, active pharmaceutical ingredients, and finished biopharmaceutical products. It also develops and produces highly controlled agricultural grow environments for plant manufacturing and replication applications. The company was formerly known as Hollyweed North Cannabis Inc. and changed its name to Lucy Scientific Discovery Inc. in May 2021. Lucy Scientific Discovery Inc. was incorporated in 2017 and is headquartered in Victoria, Canada.
Lucy Scientific Discovery Inc. management
1- Mr. Richard D. NanulaCEO & Executive Chair · born 1961